Future Market Insights has recently published a report on global hepatitis B diagnostic tests market, which studies the performance of global hepatitis B diagnostic market over ten years of forecast period. A reporter from FMI has fielded several questions on the basis of presumptive report of global hepatitis B diagnostic market.
What is your take on the expansion of global hepatitis B diagnostic tests market?
Well, the global hepatitis B diagnostic tests market is estimated to witness expansion at 6.3% CAGR during 2017-2027. The market is likely to reach US$ 1.2 Bn by the end of 2027, raised by US$ 550 Mn from the year 2017.
Why APEJ region showcases largest potential for hepatitis B diagnostics tests?
The prevalence of hepatitis B is largest in APEJ region as the disease burden is caused by chronic cases of hepatitis B. APEJ consists of large number of patients of hepatitis B, thereby it is a potential market for hepatitis B test kit manufacturers. According to statistics provided by WHO, China secures approximately one-third hepatitis B infections. Additionally, 6.2% population in the western region is likely to be infected with hepatitis B. In south-east Asia region, a projected 2% of population is infected with hepatitis B. In Australia, nearly 225 thousand people are suffering from hepatitis B. According to WHO, the prevalence of hepatitis B surface antigen is 3% to 4.2% with more than 40 million hepatitis B carriers. Owing to these high prevalence of hepatitis B in APEJ region, the market for hepatitis B diagnostic tests has huge potential in this region.
What is your take on the evolution of enzyme immunoassay kits segment?
Based on product type, the enzyme immunoassay kits segment is likely to reach valuation of approximately US$ 1.1 Bn in the year 2027, increased from US$ 590 Mn in 2017. The segment is likely to witness expansion at 6.2% CAGR during 2017-2027.
How hospital segment will perform in foreseeable future?
Hospital segment, on the basis of end-user was pegged at US$ 250 Mn in the year 2017 and is projected to reach valuation of approximately US$ 460 Mn by the end of 2027, witnessing moderate single-digit CAGR over the assessment period.
How hepatitis B diagnostic test market will perform in APEJ region?
The market in APEJ region is likely to touch valuation of approximately US$ 380 Mn by the end of 2027, up from US$ 200 Mn in the year 2017. The market in the APEJ region is likely to witness 7.2% CAGR over the forecast period.
What are the prominent players operating in the global hepatitis B diagnostic tests market?
bioMérieux SA, Meridian Bioscience, Inc., Bio-Rad Laboratories, Inc., Abbott Laboratories, DiaSorin S.p.A., Vista Diagnostics International, and Biogate Laboratories Ltd. are observed as prominent players operating in the global market. Additionally, J.Mitra & Co. Ltd., General Biologicals Corporation and Siemens Medical Solutions USA, Inc. have further consolidated their footprints in the global market.
Request Report Sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-1332